Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry stakeholders to discuss import safety

Executive Summary

An import "safety summit" being convened July 9 will feature a multi-stakeholder medical products panel moderated by FDA Commissioner Andrew von Eschenbach. The Pharmaceutical Research and Manufacturers of America publicized the summit in concert with HHS' July 1 announcement of progress in implementing the "Action Plan for Import Safety," released in November 2007. The summit is intended to facilitate input in designing remedies to import safety problems. Other cosponsors include the Biotechnology Industry Organization, the Generic Pharmaceutical Association, the Consumer Healthcare Products Association, the American National Standards Institute, and associations of the food, retail and toy industries. HHS Secretary Michael Leavitt will keynote the event

Latest Headlines
See All
UsernamePublicRestriction

Register

PS049840

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel